Teresa Iuvone

Teresa Iuvone

Auto-generated profile, based on publicly available information

Teresa Iuvone

Department of Experimental Pharmacology, Faculty of Pharmacy, University of Naples Federico II, Via D. Montesano 49, Naples, Italy

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2005 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
GEGiuseppe Esposito
Giuseppe Esposito
DFDaniele De Filippis
Daniele De Filippis
RCRosa Carnuccio
Rosa Carnuccio
AIAngelo A. Izzo
Angelo A. Izzo
TITeresa Iuvone
Teresa Iuvone

13 February 2009 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
TITeresa Iuvone
Teresa Iuvone
GEGiuseppe Esposito
Giuseppe Esposito
DFDaniele De Filippis
Daniele De Filippis
CSCaterina Scuderi
Caterina Scuderi
Luca Steardo Jr.Luca Steardo Jr.
Luca Steardo Jr.

6 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DFDaniele De Filippis
Daniele De Filippis
GEGiuseppe Esposito
Giuseppe Esposito
CCCarla Cirillo
Carla Cirillo
MCMariateresa Cipriano
Mariateresa Cipriano
BWBenedicte De Winter
Benedicte De Winter
TITeresa Iuvone
Teresa Iuvone
Enteric glial cells (EGC) actively mediate acute and chronic inflammation in the gut; EGC proliferate and release neurotrophins, growth factors, and pro-inflammatory cytokines which, in turn, may amplify the immune response, representing a very important link between the nervous and immune systems in the intestine. Cannabidiol (CBD) is an interesting compound because of its ability to control reactive gliosis in the CNS, without any unwanted psychotropic effects. Therefore the rationale of our study was to investigate the effect of CBD on intestinal biopsies from patients with ulcerative colitis (UC) and from intestinal segments of mice with LPS-induced intestinal inflammation. CBD markedly counteracted reactive enteric gliosis in LPS-mice trough the massive reduction of astroglial signalling neurotrophin S100B. Histological, biochemical and immunohistochemical data demonstrated that S100B decrease was associated with a considerable decrease in mast cell and macrophages in the intestine of LPS-treated mice after CBD treatment. Moreover the treatment of LPS-mice with CBD reduced TNF-α expression and the presence of cleaved caspase-3. Similar results were obtained in ex vivo cultured human derived colonic biopsies. In biopsies of UC patients, both during active inflammation and in remission stimulated with LPS+INF-γ, an increased glial cell activation and intestinal damage were evidenced. CBD reduced the expression of S100B and iNOS proteins in the human biopsies confirming its well documented effect in septic mice. The activity of CBD is, at least partly, mediated via the selective PPAR-gamma receptor pathway. CBD targets enteric reactive gliosis, counteracts the inflammatory environment induced by LPS in mice and in human colonic cultures derived from UC patients. These actions lead to a reduction of intestinal damage mediated by PPARgamma receptor pathway. Our results therefore indicate that CBD indeed unravels a new therapeutic strategy to treat inflammatory bowel diseases.

1 January 2011 in Molecular Pain
Verified
Journal Article
Open access
PDF file
DFDaniele De Filippis
Daniele De Filippis
Livio LuongoLivio Luongo
Livio Luongo
MCMariateresa Cipriano
Mariateresa Cipriano
EPEnza Palazzo
Enza Palazzo
MCMaria Pia Cinelli
Maria Pia Cinelli
TITeresa Iuvone
Teresa Iuvone
The aim of this study was to obtain evidences of a possible analgesic role for palmitoylethanolamide (PEA) in chronic granulomatous inflammation sustained by mast cell (MC) activation in rats at 96 hours. PEA (200-400-800 μg/mL), locally administered at time 0, reduced in a concentration-dependent manner the expression and release of NGF in comparison with saline-treated controls. PEA prevented nerve formation and sprouting, as shown by histological analysis, reduced mechanical allodynia, evaluated by Von Frey filaments, and inhibited dorsal root ganglia activation. These results were supported by the evidence that MCs in granuloma were mainly degranulated and closely localized near nerve fibres and PEA significantly reduced MC degranulation and nerves fibre formation. These findings are the first evidence that PEA, by the modulation of MC activation, controls pain perception in an animal model of chronic inflammation, suggesting its potential use for the treatment of all those painful conditions in which MC activation is an initial key step.

18 October 2007 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
DFDaniele De Filippis
Daniele De Filippis
TITeresa Iuvone
Teresa Iuvone
GEGiuseppe Esposito
Giuseppe Esposito
Luca Steardo Jr.Luca Steardo Jr.
Luca Steardo Jr.
GAG. Herman Arnold
G. Herman Arnold
BWBenedicte De Winter
Benedicte De Winter

17 April 2008 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
DFD. De Filippis
D. De Filippis
ADA. D’amico
A. D’amico
TIT. Iuvone
T. Iuvone